Navigation Links
MedicareCRM(TM) to Speak at IIR Medicare Advantage Congress
Date:1/11/2008

PITTSBURGH, Jan. 11 /PRNewswire/ -- The Institute for International Research (IIR) has selected Founders Ron Oritz and Patrick Phillips to lead a workshop on actual case studies about ways Medicare Advantage plans can increase compliance using a Web-based integration of operations, achieving new levels of cost-effective operational efficiencies. The workshop will be held 1:30 p.m. Wednesday, Jan. 23, at the 5th annual Medicare Advantage Congress in Scottsdale, Ariz. For registration information, visit MedicareCRM.com.

Premier Market Connections specializes in technology for the health care industry, with offices in Pittsburg, Penn., and as of last month, Portland, Ore. Founders Ortiz and Phillips have developed a solution to the Medicare Advantage plan's internal struggle for both compliance and the bottom-line: MedicareCRM(TM).

MedicareCRM(TM) is designed specifically for Medicare Advantage plans with user-friendly Web-based windows that:

-- Ensure all sales contact points are CMS compliant

-- Monitor lead status and progression

-- Same-day Medicare literature fulfillment

-- Enable monitoring of marketing campaigns

-- Nurture retention through member education

-- Centers for Medicare and Medicaid Services (CMS) compliance alerts

Before Ron Ortiz co-founded MedicareCRM(TM), he was a managed care senior executive and nationally known consultant to several well known managed care health plans. Fellow co-founder Patrick Phillips' tenure in healthcare informatics has been dedicated to developing process improvement strategies that have set the standard for HIPAA compliant management of protected health information. Craig Hayden, Director, Medicare Sales, Capital District Physicians Health Plan, will present alongside Ortiz and Phillips. For more information about MedicareCRM(TM) or the Medicare Advantage Congress, please visit http://www.medicarecrm.com.

Media Contacts: Woloshin Communications, Taraneh Foster, 503.241.3834 / 503.332.6309 (all hours) / tara@woloshin.com, or Mara Woloshin, 503.241.3834 / 503.310.4504 (all hours) / mara@woloshin.com


'/>"/>
SOURCE MedicareCRM
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
2. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
3. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
4. New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
5. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
6. Iomai CEO to Speak at Natixis Bleichroeder Hidden Gems Conference on Monday
7. MHA Announces: Tommy Thompson to be Keynote Speaker at The MHA 5th Annual Business Summit
8. Lux Executive Summit announces 2007 speakers
9. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
10. Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference
11. QMed, Inc. Reports July Medicare SNP Enrollments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
Breaking Biology Technology:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
Breaking Biology News(10 mins):